Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 14, Number 5—May 2008

Scale-up of Multidrug-Resistant Tuberculosis Laboratory Services, Peru

Sonya S. Shin*Comments to Author , Martin Yagui†, Luis Ascencios†, Gloria Yale‡, Carmen Suarez‡, Neyda Quispe†, Cesar Bonilla‡, Joaquin Blaya§, Allison Taylor¶, Carmen Contreras#, and Peter Cegielski¶
Author affiliations: *Brigham and Women’s Hospital, Boston, Massachusetts, USA; †Instituto Nacional de Salud, Lima, Peru; ‡Programa de Control de Tuberculosis, Lima, Peru; §Partners in Health, Boston, Massachusetts, USA; ¶Centers for Disease Control and Prevention, Atlanta, Georgia, USA; #Socios en Salud, Lima, Peru;

Main Article

Table 5

Strategies to reduce turnaround time of culture and DST, Peru*

Step Median baseline turnaround time, d Strategies used Goal turnaround time, d
From time DST processed to DST result at INS 81 Decentralize conventional and rapid DST methods 21
From receipt of DST result at intermediate laboratory to receipt of DST result at health establishment 6 Implement laboratory information system linking health centers, regional and national laboratories; improve transport of samples from health centers to regional laboratories 1
From receipt of DST result at health establishment to patient reevaluation with DST result 33 Train local providers to improve identification and referral of patients in need of MDR TB treatment; increase frequency of MDR TB treatment approval meetings; create new national culture/DST request form with DST indicators 7

*DST, drug susceptibility testing; INS, Instituto Nacional de Salud; MDR TB, multidrug-resistant tuberculosis.

Main Article

Page created: July 08, 2010
Page updated: July 08, 2010
Page reviewed: July 08, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.